Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
Reversal of refractory septic shock with drotrecogin alpha (activated)
Intensive Care Medicine, 07/02/09
Vieillard-Baron A et al. - The objective of this study was to investigate whether early administration of drotrecogin alpha (activated) (DrotAA) to this selected subgroup of septic patients at extremely high risk of death would significantly improve prognosis. DrotAA therapy was associated with unexpectedly high 28-day survival in patients with "refractory" septic shock.
Today in Critical Care...keeping you current
Receive free subspecialty "5-minute updates" via email
Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery
Critical Care, 11/06/09
Nonoperative Management of Blunt Abdominal Trauma: Have We Gone Too Far
Surgical Infections, 11/02/09
Association Between ICU Admission During Morning Rounds and Mortality
Chest, 10/12/09
Sponsor
Article Search
Sponsor


See Latest Articles


